Board of Directors


Stephen P. Bruttig Ph.D

Dr. Bruttig has a long and decorated medical research career to his credit, including red blood cell and platelet research, cell biology of vascular cells, and shock, trauma and resuscitation research at both macrovascular and microvascular levels. An active member of the American Physiological Society, Dr. Bruttig has served as president and CEO of Novel Technologies, Inc., Director of Research at Resuscitation Solutions, Inc. and was the Director of US Army Combat Casualty Care Research Program, as well as President and Program Manager of Support Systems Corporation. Dr. Bruttig has a keen expertise in the development of a wide variety of applications including the development of biopharmaceutical pre-products for trauma. A research pioneer, Dr. Bruttig has published his findings in a broad range of scholarly and technical journals, and received key awards from the University of Nebraska Medical Center while pursuing his Ph.D. 

 

   

David Ho Ph.D

Dr. Ho has been involved with several academic, government and industry organizations in managing projects related to platelet cell stabilization for wound dressing, tissue regeneration, and transfusable applications for U.S. Army and the Defense Advanced Research Projects Agency (DARPA). Dr. Ho has been actively engaging in the use of freeze-dried platelets in hard-to-heal wound management and tissue regeneration and the use of platelets and platelet-derived microparticles as hemostatic agents. Currently, Dr. Ho and his group are exploring the use of desiccation technology to desiccate red blood cells and other mammalian cells for long-term preservation and storage.

Before that, Dr. Ho was a lab chief for GTI-Novartis Pharmaceuticals and led or participated in projects where he designed and stabilized delivery vehicles to suppress growth of cancer cells, an active member of the American Society of Hematology. Dr. Ho is widely published and the holder of several patents. Dr. Ho’s formal education includes a Ph.D. from Temple University. Dr. Ho was also a co-founder of Allevex Inc., a company specializing in biochemical reagents for research and disposables for health care facilities.

 

 
Isaac L.Gadsden

Isaac L. Gadsden MBA

Isaac L. Gadsden has over 35 years experience as an executive skilled in new business development, sales and marketing management. He has extensive international and multinational team leadership experience. Ike’s expertise includes business development, business process management, supply chain management, and sales force productivity improvement as well as teaching and mentoring of new and emerging businesses. Prior to joining HeMemics Biotechnology Ike owned and operated SAMPM a management advisory firm that focused on business development for small and medium sized companies. He was on the steering committee of   Mid- Atlantic Diamond Ventures an affiliate of the Fox business School at Temple University, a new business cultivator, where he coached and mentors clients and developed relationships with the investment community

During his career in industry, Ike held a variety of staff and operational leadership assignments. His last corporate assignment was Vice president of Sales and Marketing. Other assignments included managing sales and marketing operations, strategic planning, market research, new business development and acquisition and divestitures. He has led organizations during operational and technological transitions in the US and European markets.  He has worked for E.I. DuPont, Polaroid, CBS, and Eastman Kodak.

Ike sits on of the Board of Directors of Wilmington Economic Development Corporation,  the Wilmington Chapter of Hampton University Alumni Association and the Harvard Business School Club of Philadelphia.

Ike received his BS in chemistry from Hampton University. He furthered his education at the University of Rochester in chemical engineering and subsequently earned an MBA from Harvard Business School.

 

 
 

Michael A. Berta, Ph.D

Dr. Berta earned his M.S. and Ph.D. in Physical Chemistry from the Johns Hopkins University and his B.S. from Allegheny College where he graduated Phi Beta Kappa, cum laude with honors in Chemistry. He also was a Senior Research Fellow at the California Institute of Technology and a graduate of the UCLA Executive Program. Dr. Berta has over 40 years experience in research and development and management and entrepreneurship. He is currently a business development consultant. Most recently he was Director of the Small Business Developement Center at Yuba College which assisted both new and existing businesses with business planning and financing. Previously, Dr. Berta was president and COO of an internet start-up specializing in outsourcing and business processes. For five years prior to that, he was President and CEO of RMS Technologies and its successor Intellisource which had $150 million in annual revenues. The companies provided information technology services to both the private and public sectors. During his tenure at RMS Technologies and Intellisource he had extensive experience with acquisitions and mergers and with venture capitalists and financial institutions. In additions, he has served on several boards of private companies and was President and CEO of Hughes Information Technology Company, a wholly owned subsidiary of Hughes Electronics.

 

 
 

Luther F. Schriefer

Mr. Schriefer (RADM, ret’d) is a graduate of the Naval Academy, a seasoned naval aviator and fighter pilot, and has held Command positions throughout the Navy. He was also a senior policy advisor in the Pentagon for Latin American affairs. Upon retirement, he served abroad as a General Manager for a healthcare consortium (of several companies) serving in the Middle East. More recently, he served as Chief Operating Officer for a growing biotechnology company in Maryland (also an experience in merger and acquisition), and currently holds senior positions in two other companies, one a small healthcare biotechnology company devoted to vaccines and the other fielding and selling portable hospital facilities to support remote healthcare or disaster relief.

 

 

 

 

 




Management Team

Scientific Advisory Board